• On 05 May 2021, the Food and Drug Administration (FDA) issued authorization (amended on 28 December 2021) granting Zuellig Pharma Corporation the emergency use approval of COVID-19 mRNA Vaccine (nucleoside modified) SPIKEVAX [COVID-19 Vaccine Moderna].
  
  

 Fact Sheet for Healthcare Providers Administering the Vaccine

• For more information on reporting side effects, click here.